Peisheng Hu

Peisheng Hu is a Research Assistant Professor of Pathology (Part-Time) at the University of Southern California. His work focuses on advancing immunotherapeutic strategies for cancer, particularly in CAR T-cell therapy, antibody engineering, and biomedical imaging. He has contributed to understanding the pharmacokinetics of antibody-based therapeutics and their biodistribution in preclinical models.

Research Interests: Dr. Hu's research spans CAR T-cell therapy, tumor immunology, and the development of novel immunoconjugates. He explores how engineered antibodies and fusion proteins can modulate the immune system to combat malignancies. His work also addresses challenges in targeting solid tumors and improving the efficacy of combination therapies.

Publications Highlight: Recent studies include the spatiotemporal tracking of CAR T-cells via PET imaging and the design of humanized CAR constructs with improved signaling. Earlier work includes foundational studies on antibody-CpG conjugates and fusion proteins targeting tumor-associated antigens.

Advising & Grants: No formal advisee list is provided, but his publications suggest active collaboration in translational oncology. Grants and funding details are not detailed in the provided text.